Loading clinical trials...
Loading clinical trials...
A Phase 1 Multi-Center Study to Measure the Pharmacokinetics of Oral Omadacycline in Adult Subjects With Community-Acquired Bacterial Pneumonia (CABP)
Conditions
Interventions
Omadacycline
Locations
13
United States
Site 105
Birmingham, Alabama, United States
Site 102
San Diego, California, United States
Site 104
San Diego, California, United States
Site 111
Clearwater, Florida, United States
Site 116
Clearwater, Florida, United States
Site 106
Doral, Florida, United States
Start Date
November 28, 2019
Primary Completion Date
March 23, 2020
Completion Date
April 13, 2020
Last Updated
November 3, 2021
NCT06294600
NCT07278700
NCT07164131
NCT06295120
NCT06114888
NCT02735707
Lead Sponsor
Paratek Pharmaceuticals Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions